San Francisco Chronicle; Tuesday, December 2, 1997 - Page A1
David Perlman, Chronicle Science Editor
The cells destroy the virus before it can take over the genetic machinery of other cells in the immune system and thereby prevent the invading virus from reproducing, according to Dr. Jay A. Levy, the virologist at the University of California at San Francisco who was one of the first scientists to isolate the organism that causes AIDS.
To Levy, the discovery of the protective effect of the specialized cells could be the key to developing an effective vaccine.
Levy reported on the new finding at a public meeting yesterday on the UCSF campus, marking the launch of the university's new AIDS Research Institute and at the same time commemorating the annual United Nations-sponsored World AIDS Day.
The new "institute without
walls" is designed to coordinate all the AIDS research, patient care innovations and AIDS prevention activities that are continuing at UCSF and San Francisco General Hospital.
Working in his own laboratory for more than 10 years, Levy has been investigating the mysterious properties of cells known as CD8 cells because of their unexplained ability to fight invading AIDS viruses in other immune system cells -- known as CD4 cells -- which the viruses destroy to trigger the onset of the AIDS diseases.
Levy first detected the potential anti-viral power of the CD8 cells among many men who had been infected by HIV, the AIDS virus, and yet had remained free of any hint of disease for as long as 10 to 15 years.
Most recently, Levy and his colleagues studied 56 adults and 31 children, all of whom are considered to be at high risk for AIDS. Many of the adults had been repeatedly exposed to the virus through sexual activity or intravenous drug use, and the children had been exposed while still in the womb. The most sophisticated blood tests available showed that half of the adults and young children remained free of the virus and had not even produced antibodies despite their exposure, Levy said.
According to Levy, the activity of the CD8 cells appears to be controlled by a mysterious protein which neither he nor other scientists have yet to identify completely, but which Levy calls CAF, for CD8 Anti-viral Factor.
In their laboratory experiments, Levy and his colleagues found that the CD4 cells in the blood of all the volunteer subjects were easily susceptible to infection by HIV, but in half the group, CD8 cells blocked the virus from reproducing and protected the invaded CD4 cells from destruction.
In Levy's theory, an attack by small amounts of virus can induce the CD8 cells to start a "cellular immune anti-viral response" and "each subsequent exposure then acts as a kind of booster."
"We seem to have found a natural immune response produced by the virus itself that acts like a vaccination," Levy said in an interview.
As a result, he said, he and his colleagues are intensifying their search for a way to exploit the CD8 cells and the unidentified protein factor that regulates their activity as the key to a full-fledged AIDS vaccine.
Under the aegis of the newly formed AIDS Research Institute at UCSF, Levy said, a broad-based new AIDS vaccine quest is about to begin. It will involve scientists at UC Davis and Stanford as well as UCSF, he said, and will also include researchers at Chiron and Genentech, two leading Bay Area biotechnology companies.
Levy's UCSF colleagues include cancer researcher Sharon Stranford and pediatricians Diane Wara and Peggy Weintrub. The new research will also be discussed today and tomorrow at an international workshop on AIDS vaccines on the UCSF campus.
971202
SC971202
Copyright © 1997 - San Francisco Chronicle Press. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the San Francisco Chronicle, Permissions Desk, 901 Mission Street, San Franciso, CA 94103. You may also send a fax to (415) 495-3843, or an email message to chronperm@sfgate.com. http://www.sfgate.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .